How did Bayer AG's revenue change from 2023 to 2024?

Bayer AG reported $50.8B in revenue for fiscal year 2024. This represents a -2.1% change compared to 2023. Revenue slipped roughly 2.1% to $50.8 billion in 2024 as glyphosate price competition and Xarelto generic erosion offset growth from Nubeqa and Kerendia.

FY2024 Revenue

$50.8B

▼ 2.1% vs FY2023 ($51.9B)

Source: Annual report / company filing

Bayer AG reported $50.8B in revenue for fiscal year 2024. This represents a decline of 2.1% compared to the 2023 figure of $51.9B. In 2025, revenue declined to $49.5B.

Revenue slipped roughly 2.1% to $50.8 billion in 2024 as glyphosate price competition and Xarelto generic erosion offset growth from Nubeqa and Kerendia.

Revenue by Year

FY2025 FY2024 FY2023 FY2022

Bayer AG Annual Revenue History

Year	Revenue	YoY Change
FY2025	$49.5B	-2.6%
FY2024	$50.8B	-2.1%
FY2023	$51.9B	+2.4%
FY2022	$50.7B	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

← Previous year

FY2023: $51.9B

Next year →

FY2025: $49.5B

Explore Bayer AG

Core profile pages, annual revenue records, and related research hubs for this company.